| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | An E.coli-derived zebrafish Kv1.2/Kcna2a recombinant protein (amino acids E437-V493) was used as the immunogen for the Zebrafish Kv1.2 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
Zebrafish Kv1.2 Antibody / Kcna2a is an antibody targeting Kv1.2. Host: Rabbit. Polyclonal. Format: Antigen affinity purified. Applications: WB.
Key elements and design rationale
- Target: Kv1.2.
- Immunogen: An E.coli-derived zebrafish Kv1.2/Kcna2a recombinant protein (amino acids E437-V493) was used as the immunogen for the….
- Species reactivity: Zebrafish.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
The Kv1.2 protein in zebrafish is a voltage-gated potassium channel subunit encoded by the kcna2a and kcna2b genes, which are paralogs resulting from the teleost-specific whole genome duplication.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
